M&A Deal Summary |
|
|---|---|
| Date | 2024-03-13 |
| Target | Specac |
| Sector | Manufacturing |
| Buyer(s) | Ampersand Capital Partners |
| Sellers(s) | Foresight Private Equity |
| Deal Type | Secondary Buyout |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 80 of 84 |
| Sector (Manufacturing) | 2 of 2 |
| Type (Secondary Buyout) | 6 of 7 |
| Country (United Kingdom) | 2 of 2 |
| Year (2024) | 1 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-11-28 |
Julius Clinical Research
Zeist, Netherlands Julius Clinical Research is a scientifically focused CRO providing end-to-end clinical trial service to pharmaceutical and biotechnology customers, governments, and academia. The company combines operational excellence and a global network of research sites to deliver tailor-made solutions for customers and their clinical trials. Julius Clinical Research was formed in 2008 and is based in Zeist, Netherlands. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-19 |
Biologos
Montgomery, Illinois, United States Biologos is a provider of sterile-filtered biological products (sera, reagents, buffers, cell culture media and other liquid solutions), primarily for veterinary pharmaceutical and organ transplant applications. Biologos was founded in 1976 and is based in Montgomery, Illinois. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1984 |
| PE ASSETS | 600M GBP |
| Size | Middle-Market |
| Type | Sector Agnostic |
Foresight Group LLP (Formerly VCF Partners)
| DEAL STATS | # |
|---|---|
| Overall | 41 of 42 |
| Sector (Manufacturing) | 3 of 3 |
| Type (Secondary Buyout) | 9 of 9 |
| Country (United Kingdom) | 40 of 41 |
| Year (2024) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-07-05 |
KSL Clinic
Kent, United Kingdom KSL Clinic delivers FUE hair transplant treatments by offering complete hair restoration, for men and women of all ages suffering from baldness/hair loss. KSL Clinic is based in Kent. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-09-17 |
Substantive Research
London, United Kingdom Substantive Research is a provider of research analysis for asset managers. Substantive Research provides valuable benchmarking data, coverage analysis, analyst moves and new provider tracking, tailored to each client’s investment process and coverage requirements. Substantive Research was founded in 2015 and is based in London, England. |
Sell | - |
